including cognitive decline, cancer, metabolic disease, sarcopenia (loss of muscle mass) and frailty
Studies show that L-theanine promotes calm, relaxed alertness
Many insurance providers, such as Medicare, usually do not cover weight loss medications such as Zepbound and Wegovy
They have launched AMPLIFY ( A mplifying M eaningful P erspectives and L ived experiences of I ncretin therapy use F rom diverse communit Y voices) to understand how people experience next-generation weight loss therapies when used for weight management
When starting GLP-1 therapy, your appetite naturally drops, which can reduce overall fiber consumption
In order to limit GLP-1 costs and prioritize the cohorts most at risk, payers should develop a risk stratification rubric to segment and prioritize patients for GLP-1 weight loss coverage in cases where it is medically necessary and/or where cost of care can be lowered the most